Ramin Saravani1,2, Davood Yari3,4, Samira Saravani5, Farzaneh Hasanian-Langroudi2. 1. Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. 2. Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. 3. Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. Davidyari.85@gmail.com. 4. Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran. Davidyari.85@gmail.com. 5. Department of Molecular Genetics, University of Zabol, Zabol, Iran.
Abstract
PURPOSE: Keratoconus (KC) is thinning of the central cornea. Its etiology is unknown, but it may result from degrading of collagen type IV. The major protein in the cornea is collagen. Matrix metalloproteinase-9 (MMP-9) is able to degrade collagen type IV from the basement membrane and extracellular matrix (ECM). MMP-9 enzymatic activity is inhibited by the tissue inhibitor of metalloproteinase-1 (TIMP-1). In the present study, we sought to investigate and evaluate the effects of single nucleotide polymorphisms in COL4A3, MMP-9, and TIMP-1 on the risk of KC in an Iranian population sample. METHODS: This case-control study was performed on 140 KC patients and 150 healthy controls. Genotyping of the COL4A3 rs55703767, MMP-9 rs17576, and TIMP-1 rs6609533 polymorphisms was done using amplification refractory mutation system polymerase chain reaction (ARMS-PCR). RESULTS: Our findings showed that the rs55703767G/T polymorphism decreased the risk of KC (OR = 0.26, 95% CI = 0.08-0.82, P = 0.022). rs17576A/G, associated with KC and the A allele, was significantly overrepresented in healthy individuals. rs6609533A/G (X-chromosome) increased the risk of KC in females (OR = 2.27, 95% CI = 1.06-4.76, P = 0.036). In males, the allele frequency was not associated with KC risk/protection. CONCLUSIONS: This study indicates that in our population, the COL4A3 rs55703767 polymorphism decreased the risk of KC. However, the TIMP-1 rs6609533 polymorphism was associated with an increased risk of KC.
PURPOSE: Keratoconus (KC) is thinning of the central cornea. Its etiology is unknown, but it may result from degrading of collagen type IV. The major protein in the cornea is collagen. Matrix metalloproteinase-9 (MMP-9) is able to degrade collagen type IV from the basement membrane and extracellular matrix (ECM). MMP-9 enzymatic activity is inhibited by the tissue inhibitor of metalloproteinase-1 (TIMP-1). In the present study, we sought to investigate and evaluate the effects of single nucleotide polymorphisms in COL4A3, MMP-9, and TIMP-1 on the risk of KC in an Iranian population sample. METHODS: This case-control study was performed on 140 KC patients and 150 healthy controls. Genotyping of the COL4A3rs55703767, MMP-9rs17576, and TIMP-1rs6609533 polymorphisms was done using amplification refractory mutation system polymerase chain reaction (ARMS-PCR). RESULTS: Our findings showed that the rs55703767G/T polymorphism decreased the risk of KC (OR = 0.26, 95% CI = 0.08-0.82, P = 0.022). rs17576A/G, associated with KC and the A allele, was significantly overrepresented in healthy individuals. rs6609533A/G (X-chromosome) increased the risk of KC in females (OR = 2.27, 95% CI = 1.06-4.76, P = 0.036). In males, the allele frequency was not associated with KC risk/protection. CONCLUSIONS: This study indicates that in our population, the COL4A3rs55703767 polymorphism decreased the risk of KC. However, the TIMP-1rs6609533 polymorphism was associated with an increased risk of KC.
Authors: C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham Journal: Nucleic Acids Res Date: 1989-04-11 Impact factor: 16.971
Authors: Emma Arnal; Cristina Peris-Martínez; Jose Luis Menezo; Siv Johnsen-Soriano; Francisco Javier Romero Journal: Invest Ophthalmol Vis Sci Date: 2011-11-04 Impact factor: 4.799
Authors: Davood Yari; Mohammad H Ebrahimzadeh; Jebrail Movaffagh; Azadeh Shahroodi; Moein Shirzad; Durdi Qujeq; Ali Moradi Journal: Arch Bone Jt Surg Date: 2022-03